In light of the inferred associations between HER3, HER2, MMP activity and brain metastases, and the ubiquitous expression of heregulin in the brain, we hypothesized that heregulin may activate molecular mechanisms conducive to the establishment and growth of HER2-positive breast cancer cells in the brain microenvironment. The gene discussed is NRG1; the disease is breast cancer.